Johnson & Johnson Portfolio Holdings

Johnson & Johnson

  • $290 Million
  • Q2 2024

Johnson & Johnson has filed its 13F form on August 09, 2024 for Q2 2024 where it was disclosed a total value porftolio of $290 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $84.9M, Cv Rx, Inc. with a value of $49.2M, Legend Biotech Corp with a value of $36.1M, Nanobiotix S.A. with a value of $28.1M, and Meira G Tx Holdings PLC with a value of $28M.

Examining the 13F form we can see an decrease of $185M in the current position value, from $475M to 290M.

Johnson & Johnson is based out at New Brunswick, NJ

Below you can find more details about Johnson & Johnson portfolio as well as his latest detailed transactions.

Portfolio value $290 Million
Healthcare: $290 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $290 Million
  • Prior Value $475 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 09, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 3 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email